China SXT Pharmaceuticals Inc (SXTC) — Cash Flow-to-Debt Ratio
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2025, meaning its operating cash flow of $-494.08K could theoretically repay 0% of its total liabilities ($6.22 Million) in one year. See China SXT Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China SXT Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for China SXT Pharmaceuticals Inc across 10 annual periods. Also explore SXTC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for China SXT Pharmaceuticals Inc (2016–2025)
Year-by-year debt coverage analysis for China SXT Pharmaceuticals Inc. For market capitalisation and broader financial context, see China SXT Pharmaceuticals Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.38x | $-2.35 Million | $6.22 Million | ▼ -79.7% |
| 2024 | -0.21x | $-1.93 Million | $9.20 Million | ▼ -3758.4% |
| 2023 | -0.01x | $-80.76K | $14.86 Million | ▼ -134.7% |
| 2022 | 0.02x | $268.29K | $17.12 Million | ▲ +122.1% |
| 2021 | -0.07x | $-1.32 Million | $18.59 Million | ▼ -193.3% |
| 2020 | 0.08x | $934.25K | $12.30 Million | ▲ +102.0% |
| 2019 | 0.04x | $239.19K | $6.36 Million | ▼ -91.4% |
| 2018 | 0.44x | $1.92 Million | $4.37 Million | ▲ +436.4% |
| 2017 | 0.08x | $293.04K | $3.58 Million | ▲ +149.2% |
| 2016 | 0.03x | $182.47K | $5.55 Million | — |